Immunotherapy of solid tumors by vaccination with transgenic leishmania expressing cancer vaccines and with recombinant vaccines with leishmania as adjuvants
US2019357832A1
System and Method for Determining a Discrimination Index for Fear-Potentiated Startle
EP3724335A1
Antisense compounds targeting leucine-rich repeat kinase 2 (lrrk2) for the treatment of parkinsons disease
US2018318408A1
Immunotherapy of canine leishmaniasis
US2018094266A1
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
US2018117073A1
Antisense compounds targeting genes associated with cystic fibrosis
WO2018093838A1
Intelligent offloading insole device
US2017295793A1
Photodynamic insecticides
US2017281574A1
Method and kit for treating a solid tumor and associated desmoplasia
US2018233059A1
Methods and Systems for Improving Patient Outcomes
WO2017087282A1
Antisense compounds targeting leucine-rich repeat kinase 2 (lrrk2) for the treatment of parkinsons disease
US2017042989A1
Photosensitized trypanosomatids and vaccine compositions thereof
US2016244767A1
Antisense compounds targeting genes associated with cystic fibrosis
US2016166193A1
Mobile sensor system and methods for use
US2016244833A1
Methods and kits for diagnosing, prognosing and monitoring parkinson's disease
US2016244832A1
Methods and kits for diagnosing, prognosing and monitoring parkinson's disease
US2016024038A1
Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
US2015305664A1
Foot-strength test device and methods for use
US2014315761A1
Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
US2014275112A1
Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
